Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth Emerges as a Core Driver of the mRNA Cancer Vaccines And Therapeutics Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the mRNA Cancer Vaccines And Therapeutics Market Through 2025?
In recent times, the market size for mRNA cancer vaccines and therapeutics has witnessed a rapid expansion. Expected to surge from $61.52 billion in 2024 to $71.85 billion in 2025, it is forecasted to grow at a compound annual growth rate (CAGR) of 16.8%. The historical growth is ascribed to factors like changes in lifestyle, financial backing, a conducive regulatory scenario, well-settled healthcare infrastructure, and dynamic pipeline development.

What's the Projected Size of the Global mRNA Cancer Vaccines And Therapeutics Market by 2029?
There is a projected swift surge in the market size of mRNA cancer vaccines and therapeutics in the ensuing years. By 2029, it is anticipated to touch $131.99 billion, accounting for a compound annual growth rate (CAGR) of 16.4%. This expansion during the forecast period can be credited to promising results of clinical trials, increasing recognition and adoption of mRNA technology, unmet medical needs in the sphere of cancer treatment, potential for improved patient outcomes, and possible off-the-shelf availability. Key trends expected to shape the forecast period involve expansion into new therapeutic areas, personalized medicine initiatives, progression in mRNA delivery systems, multivalent mRNA vaccines, and the incorporation of artificial intelligence and machine learning in mRNA design.

View the full report here:
https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

Top Growth Drivers in the mRNA Cancer Vaccines And Therapeutics Industry: What's Accelerating the Market?
The increasing occurrence of cancer is predicted to fuel the advancement of the mRNA cancer vaccine and therapeutic market. Cancer encompasses a variety of diseases marked by the unchecked proliferation and spread of abnormal cells, which invade and eradicate healthy body tissues. This escalation in cancer prevalence stems from sedentary ways of living, unhealthy dietary patterns, and exposure to environmental toxins. mRNA cancer vaccines and treatments are necessary for tackling cancer because they provide personalized, targeted interventions that can boost the immune system's capacity to identify and combat cancerous cells, enhancing the effectiveness of treatment and patient outcomes. For example, data revealed by the American Cancer Society, an American non-profit organization dedicated to eradicating cancer, in January 2023 showed an estimated 1,918,030 new cancer cases in the United States in 2022, increasing to 1,958,310 in 2023. Breast cancer is the highest chronic disease in the United States, surging from 287,850 cases in 2022 to 297,790 cases in 2023. Therefore, the surge in cancer prevalence is stimulating the growth of the mRNA cancer vaccines and therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

What Trends Will Shape the mRNA Cancer Vaccines And Therapeutics Market Through 2029 and Beyond?
Key players in the mRNA cancer vaccine and therapeutics market are concentrating on the development of novel treatments like mRNA cancer vaccines to increase effectiveness, better patient outcomes, and meet the rising need for successful cancer therapies. mRNA cancer vaccines, a form of immunotherapy, employ messenger RNA to direct cells to generate specific antigens, triggering the immune system to identify and combat cancer cells. For instance, in May 2024, WestGene Biopharma, a biotech firm from China, acquired FDA approval for its investigational new drug application for its mRNA therapeutic cancer vaccine, WGc-043. This FDA approval of WGc-043 signifies a considerable advance in treating advanced EB virus-related cancers. These cancers are notably associated with more than ten types of malignancies, encompassing nasopharyngeal carcinoma, NK T-cell lymphoma, and cancers of the stomach, lung, liver, esophagus, breast, and cervix, as well as autoimmune ailments like multiple sclerosis and lupus.

What Are the Main Segments in the mRNA Cancer Vaccines And Therapeutics Market?
The mRNA cancer vaccines and therapeutics market covered in this report is segmented -

1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17204&type=smp

Which Top Companies are Driving Growth in the mRNA Cancer Vaccines And Therapeutics Market?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.

Which Regions Will Dominate the mRNA Cancer Vaccines And Therapeutics Market Through 2029?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17204

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.